Mireia Lopez Corbeto I graduated in Medicine from the University of Barcelona and in 2017 I completed my training in Rheumatology at the Vall d'Hebron University Hospital. During my formative period I did a four month training stay at the University of Alabama and Children's Hospital at Birmingham (Alabama, United States) in Pediatric Rheumatology. At the end of the residency I combined care tasks at the Pediatric Rheumatology Unit with research, developing my PhD program in the framework of a study funded by the Carlos III Health Research Fund (FIS), focused on the study of Juvenile Idiopathic Arthritis and precision medicine. I recently completed a study placement at the HudsonAlpha Institute for Biotechnology (Alabama, USA) focused on computational biology and bioinformatics. I continue my educational activity pursuing the Master's Degree in Research Methodology in Health Sciences of the Autonomous University of Barcelona, and I participate in national and international courses, congresses and scientific conferences in the field of Pediatric Rheumatology. I take an active part in the spread of childhood rheumatic diseases in training courses for professionals and workshops for families. Instituciones de las que forman parte Investigador/a principal Reumatología Vall Hebron Institut de Recerca Médico Reumatología Hospital Traumatologia, Rehabilitació i Cremats Mireia Lopez Corbeto Instituciones de las que forman parte Investigador/a principal Reumatología Vall Hebron Institut de Recerca Médico Reumatología Hospital Traumatologia, Rehabilitació i Cremats I graduated in Medicine from the University of Barcelona and in 2017 I completed my training in Rheumatology at the Vall d'Hebron University Hospital. During my formative period I did a four month training stay at the University of Alabama and Children's Hospital at Birmingham (Alabama, United States) in Pediatric Rheumatology. At the end of the residency I combined care tasks at the Pediatric Rheumatology Unit with research, developing my PhD program in the framework of a study funded by the Carlos III Health Research Fund (FIS), focused on the study of Juvenile Idiopathic Arthritis and precision medicine. I recently completed a study placement at the HudsonAlpha Institute for Biotechnology (Alabama, USA) focused on computational biology and bioinformatics. I continue my educational activity pursuing the Master's Degree in Research Methodology in Health Sciences of the Autonomous University of Barcelona, and I participate in national and international courses, congresses and scientific conferences in the field of Pediatric Rheumatology. I take an active part in the spread of childhood rheumatic diseases in training courses for professionals and workshops for families.
I am an assistant doctor in the Rheumatology service and I develop my medical activity in the Pediatric Rheumatology and Rheumatology unit of the young adult. The Unit offers a comprehensive follow-up of pediatric patients through outpatient clinics and evaluation of patients admitted with pediatric rheumatic pathology. We also evaluate pediatric musculoskeletal pathology with joint ultrasound and diagnostic-therapeutic tests such as arthrocentesis and joint infiltration.
Proyectos Caracterización por single cell RNA-seq de las células T patogénicas en la artritis idiopática juvenil oliogarticular, estudio de aplicabilidad translacional. IP: Mireia Lopez Corbeto Colaboradores: - Entidad financiadora: Sociedad Española de Reumatología Pediátrica SERP Financiación: 8000 Referencia: SERPE/REUMAPED/2022/LOPEZ Duración: 30/12/2022 - 29/12/2024 ESTUDI DE SEGURETAT I IMMUNOGENICITAT VACUNAL EN PACIENTS PEDIÀTRICS AMB MALALTIES REUMÀTIQUES IP: Mireia Lopez Corbeto Colaboradores: - Entidad financiadora: Stat Catalana Reumatologia – ACMSCB Financiación: 6000 Referencia: SCR/BECAABBIE/2020/LOPEZ Duración: 01/01/2020 - 31/03/2021 Caracterización de RNA-seq de células individuales de células T CD4 + patológicas en artritis idiopática juvenil oligoarticular y estudio de aplicabilidad traslacional IP: Sara Marsal Barril Colaboradores: Nuria Palau Balaña, Luis Riera Soler, Estefania Moreno Ruzafa, Mireia Lopez Corbeto, Adria Aterido Ballonga Entidad financiadora: Instituto de Salud Carlos III Financiación: 208120 Referencia: PI19/00225 Duración: 01/01/2020 - 30/06/2024 Estudio de las enfermedades inflamatorias mediadas por inmunidad (Immuno-mediated Inflammatory Diseases, IMIDs) en el marco de la Medicina de Precisión. IP: Sara Marsal Barril Colaboradores: Mireia Lopez Corbeto, Laia Perez Lasarte Entidad financiadora: Instituto de Salud Carlos III Financiación: 53732 Referencia: CM18/00012 Duración: 01/01/2019 - 09/01/2022
